Alzex Neuropharma Inc (TRRI)

OTC Markets

Currency in USD

0.071

0.000(0.00%)

Closed·21/04

Fair Value

Unlock Value

Day's Range

0.071

52 wk Range

0.001

0.198

TRRI Income Statement

Featured here, the Income Statement (earnings report) for Alzex Neuropharma Inc, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Period Ending:

2006

31/12

2007

31/12

2008

31/12

2009

31/12

2010

31/12

2011

31/12

Total Revenues

aa.aa

4.73

Total Revenues Growth

aa.aa

+23.83%

Cost Of Revenues

aa.aa

4.3

Gross Profit

aa.aa

0.43

Gross Profit Growth

aa.aa

-5.02%

Gross Profit Margin %

aa.aa

9.09%

Other Operating Expenses, Total

aa.aa

0.49

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+42.67%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	0.42
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-

Operating Income

aa.aa

-0.06

Operating Income Growth

aa.aa

-148.92%

EBIT Margin %

aa.aa

-1.16%

Net Interest Expenses

aa.aa

-0.01

Net Interest Expenses Growth

aa.aa

+74.88%

Interest Expense, Total

aa.aa

-0.01

Interest And Investment Income

aa.aa

Other Non Operating Expenses, Total

aa.aa

0.1

EBT, Excl. Unusual Items

aa.aa

0.03

Gain (Loss) On Sale Of Assets

aa.aa

Other Unusual Items, Total

aa.aa

EBT, Incl. Unusual Items

aa.aa

0.03

EBT, Incl. Unusual Items Growth

aa.aa

-59.83%

EBT, Incl. Unusual Items Margin

aa.aa

0.68%

Income Tax Expense

aa.aa

Net Income to Company

aa.aa

0.03

Minority Interest

aa.aa

Net Income

aa.aa

0.03

Net Income Growth

aa.aa

-59.83%

Net Income Margin %

aa.aa

0.68%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

0.03

Basic EPS - Continuing Operations

aa.aa

Basic EPS - Continuing Operations Growth

aa.aa

Diluted EPS - Continuing Operations

aa.aa

Diluted EPS - Continuing Operations Growth

aa.aa

Basic Weighted Average Shares Outstanding

aa.aa

Diluted Weighted Average Shares Outstanding

aa.aa

Dividend Per Share

aa.aa

Dividend Per Share Growth

aa.aa

EBITDA

aa.aa

0.01

EBITDA Growth

aa.aa

-94.97%

EBITDA Margin %

aa.aa

0.2%

EBIT

aa.aa

-0.06

* In Millions of USD (except for per share items)

FAQ

What was Alzex Neuropharma’s revenue at year end?

At the end of the last reported fiscal year, Alzex Neuropharma (TRRI) recorded total revenue of 4.734.

How much revenue did Alzex Neuropharma report in the most recent quarter?

In its most recent quarterly earnings report, Alzex Neuropharma posted revenue of 0.92.

What was Alzex Neuropharma’s net income for the year?

For the full year, Alzex Neuropharma reported net income of 0.032.

How much net income did Alzex Neuropharma post in the last quarter?

In the most recent quarter, Alzex Neuropharma (TRRI) posted net income of -0.05.

What was Alzex Neuropharma’s gross profit for the year?

Gross profit for the year was reported at 0.430.

How much gross profit did Alzex Neuropharma generate last quarter?

Alzex Neuropharma recorded gross profit of 0.128 in its latest quarterly report.

What was Alzex Neuropharma’s annual operating income?

For the full year, Alzex Neuropharma (TRRI) reported operating income of -0.055.

What was Alzex Neuropharma’s operating income last quarter?

Quarterly operating income was -0.062.

What was Alzex Neuropharma’s quarterly EBITDA?

In the latest quarter, EBITDA was reported at -0.033.

What was the quarter-over-quarter change in EBITDA for Alzex Neuropharma?

EBITDA changed by -236.103% compared to the last quarter.

What is Alzex Neuropharma’s most recent gross profit margin?

The latest reported gross profit margin for Alzex Neuropharma (TRRI) is 14.006%.

What is Alzex Neuropharma’s most recent net income margin?

Net income margin based on recent financials is -5.973%.

What is Alzex Neuropharma’s most recent EBIT margin?

Alzex Neuropharma reported an EBIT margin of -6.723% based on current figures.

How did Alzex Neuropharma’s revenue change compared to the previous quarter?

Revenue changed by -1.550% compared to the prior quarter.

What was the quarter-over-quarter change in gross profit for Alzex Neuropharma?

In the latest quarter 2026, gross profit changed by 428.343% from the previous quarter.

S&P/TSX

33,176.07

+79.67

+0.24%

S&P/TSX 60

1,909.13

+1.65

+0.09%

US 30

49,006.20

+2.8

+0.01%

US 500

6,979.00

+0.4

+0.01%

S&P 500 VIX

16.54

+0.19

+1.16%

DAX

24,822.79

-71.65

-0.29%

Dollar Index

96.22

+0.160

+0.17%

Market Movers

Name	Last	Chg. %	Vol.
Enbridge	65.80	+0.94%	11.38M
Barrick Mining	71.86	+1.41%	6.85M
RBC	225.93	-1.42%	6.84M
Bank of Montreal	188.81	+0.75%	6.66M
TC Energy	78.78	+0.55%	6.13M
Bank of Nova Scotia	102.08	-1.38%	5.90M
Toronto Dominion Bank	126.90	-2.70%	5.57M

Name	Last	Chg. %	Vol.
Grounded People Apparel	0.100	+1,900.00%	2.50K
Moss Genomics	0.07	+1,400.00%	44.20K
PeakBirch Logic	0.030	+500.00%	1.32K
New Leaf Ventures	0.05	+400.00%	666.82K
Irwin Naturals	0.30	+150.00%	3.24K
Green Scientific Labs Holdings	0.06	+120.00%	15.00K
Ginsms	0.0100	+100.00%	265.00K

Name	Last	Chg. %	Vol.
Metamaterial	0.25	-92.86%	0.00
DLC Holdings	0.04	-57.89%	12.00K
Starlo Ventures	0.32	-55.00%	5.10K
Highrock Resources	0.04	-53.33%	10.00K
Molecule Holdings	0.005	-50.00%	20.11K
MyndTec	0.01	-50.00%	40.00K
Playgon Games	0.0050	-50.00%	20.00K

Trending Stocks

Name	Last	Chg. %	Vol.
Celestica Inc.	467.12	+3.29%	878.72K
Canadian Imperial Bank	126.33	-0.46%	3.25M
Hut 8	87.570	+4.32%	1.74M
Canadian Natural	50.23	+0.84%	6.53M
Constellation Software	2,640.06	-0.42%	123.91K

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaaaaaaaaa A A	85.41	+70.58%	145.69
A Aaaaaa	21.64	+55.58%	33.67
Aa A Aaaaa Aaa	37.10	+52.24%	56.48
Aaaaaaaaa Aaaaaaaa	18.69	+48.85%	27.82
Aaaaa	2,640.06	+44.38%	3,811.72
Aaaaaaaaaa Aa	63.72	+43.14%	91.21
Aaaaaaaa Aaaaaa	30.60	+40.14%	42.88

Name	Last	Upside	Fair Value
Aaaaaaaaaa A A	85.41	+70.58%	145.69
A Aaaaaa	21.64	+55.58%	33.67
Aa A Aaaaa Aaa	37.10	+52.24%	56.48
Aaaaaaaaa Aaaaaaaa	18.69	+48.85%	27.82
Aaaaa	2,640.06	+44.38%	3,811.72
Aaaaaaaaaa Aa	63.72	+43.14%	91.21
Aaaaaaaa Aaaaaa	30.60	+40.14%	42.88

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

Alzex Neuropharma Inc (TRRI)

TRRI Income Statement

FAQ

What was Alzex Neuropharma’s revenue at year end?

How much revenue did Alzex Neuropharma report in the most recent quarter?

What was Alzex Neuropharma’s net income for the year?

How much net income did Alzex Neuropharma post in the last quarter?

What was Alzex Neuropharma’s gross profit for the year?

How much gross profit did Alzex Neuropharma generate last quarter?

What was Alzex Neuropharma’s annual operating income?

What was Alzex Neuropharma’s operating income last quarter?

What was Alzex Neuropharma’s quarterly EBITDA?

What was the quarter-over-quarter change in EBITDA for Alzex Neuropharma?

What is Alzex Neuropharma’s most recent gross profit margin?

What is Alzex Neuropharma’s most recent net income margin?

What is Alzex Neuropharma’s most recent EBIT margin?

How did Alzex Neuropharma’s revenue change compared to the previous quarter?

What was the quarter-over-quarter change in gross profit for Alzex Neuropharma?

Trending Stocks